S E Gullbrand1, N R Malhotra2, T P Schaer3, Z Zawacki3, J T Martin4, J R Bendigo1, A H Milby5, G R Dodge4, E J Vresilovic6, D M Elliott7, R L Mauck4, L J Smith8. 1. Translational Musculoskeletal Research Center, Philadelphia VA Medical Center, Philadelphia, PA, United States; McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, United States; Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, United States. 2. Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, United States. 3. Comparative Orthopaedic Research Laboratory, School of Veterinary Medicine, University of Pennsylvania, Kennett Square, PA, United States. 4. Translational Musculoskeletal Research Center, Philadelphia VA Medical Center, Philadelphia, PA, United States; McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, United States. 5. McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, United States. 6. Penn State Hershey Bone and Joint Institute, Pennsylvania State University, Hershey, PA, United States. 7. Department of Biomedical Engineering, University of Delaware, Newark, DE, United States. 8. Translational Musculoskeletal Research Center, Philadelphia VA Medical Center, Philadelphia, PA, United States; McKay Orthopaedic Research Laboratory, Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, United States; Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: lachlans@mail.med.upenn.edu.
Abstract
OBJECTIVE: The objective of this study was to establish a large animal model that recapitulates the spectrum of intervertebral disc degeneration that occurs in humans and which is suitable for pre-clinical evaluation of a wide range of experimental therapeutics. DESIGN: Degeneration was induced in the lumbar intervertebral discs of large frame goats by either intradiscal injection of chondroitinase ABC (ChABC) over a range of dosages (0.1U, 1U or 5U) or subtotal nucleotomy. Radiographs were used to assess disc height changes over 12 weeks. Degenerative changes to the discs and endplates were assessed via magnetic resonance imaging (MRI), semi-quantitative histological grading, microcomputed tomography (μCT), and measurement of disc biomechanical properties. RESULTS: Degenerative changes were observed for all interventions that ranged from mild (0.1U ChABC) to moderate (1U ChABC and nucleotomy) to severe (5U ChABC). All groups showed progressive reductions in disc height over 12 weeks. Histological scores were significantly increased in the 1U and 5U ChABC groups. Reductions in T2 and T1ρ, and increased Pfirrmann grade were observed on MRI. Resorption and remodeling of the cortical boney endplate adjacent to ChABC-injected discs also occurred. Spine segment range of motion (ROM) was greater and compressive modulus was lower in 1U ChABC and nucleotomy discs compared to intact. CONCLUSIONS: A large animal model of disc degeneration was established that recapitulates the spectrum of structural, compositional and biomechanical features of human disc degeneration. This model may serve as a robust platform for evaluating the efficacy of therapeutics targeted towards varying degrees of disc degeneration.
OBJECTIVE: The objective of this study was to establish a large animal model that recapitulates the spectrum of intervertebral disc degeneration that occurs in humans and which is suitable for pre-clinical evaluation of a wide range of experimental therapeutics. DESIGN: Degeneration was induced in the lumbar intervertebral discs of large frame goats by either intradiscal injection of chondroitinase ABC (ChABC) over a range of dosages (0.1U, 1U or 5U) or subtotal nucleotomy. Radiographs were used to assess disc height changes over 12 weeks. Degenerative changes to the discs and endplates were assessed via magnetic resonance imaging (MRI), semi-quantitative histological grading, microcomputed tomography (μCT), and measurement of disc biomechanical properties. RESULTS: Degenerative changes were observed for all interventions that ranged from mild (0.1U ChABC) to moderate (1U ChABC and nucleotomy) to severe (5U ChABC). All groups showed progressive reductions in disc height over 12 weeks. Histological scores were significantly increased in the 1U and 5U ChABC groups. Reductions in T2 and T1ρ, and increased Pfirrmann grade were observed on MRI. Resorption and remodeling of the cortical boney endplate adjacent to ChABC-injected discs also occurred. Spine segment range of motion (ROM) was greater and compressive modulus was lower in 1U ChABC and nucleotomy discs compared to intact. CONCLUSIONS: A large animal model of disc degeneration was established that recapitulates the spectrum of structural, compositional and biomechanical features of humandisc degeneration. This model may serve as a robust platform for evaluating the efficacy of therapeutics targeted towards varying degrees of disc degeneration.
Authors: Marc-Antoine A Rousseau; Jill A Ulrich; Elisa C Bass; Azucena G Rodriguez; Jane J Liu; Jeffrey C Lotz Journal: Spine (Phila Pa 1976) Date: 2007-01-01 Impact factor: 3.468
Authors: Jesse C Beckstein; Sounok Sen; Thomas P Schaer; Edward J Vresilovic; Dawn M Elliott Journal: Spine (Phila Pa 1976) Date: 2008-03-15 Impact factor: 3.468
Authors: Mirte Peeters; Suzanne E L Detiger; Lindsay S Karfeld-Sulzer; Theo H Smit; Avner Yayon; Franz E Weber; Marco N Helder Journal: Biores Open Access Date: 2015-10-01
Authors: Sarah E Gullbrand; Thomas P Schaer; Prateek Agarwal; Justin R Bendigo; George R Dodge; Weiliam Chen; Dawn M Elliott; Robert L Mauck; Neil R Malhotra; Lachlan J Smith Journal: Acta Biomater Date: 2017-07-19 Impact factor: 8.947
Authors: Matthew Piazza; Sun H Peck; Sarah E Gullbrand; Justin R Bendigo; Toren Arginteanu; Yejia Zhang; Harvey E Smith; Neil R Malhotra; Lachlan J Smith Journal: J Orthop Res Date: 2018-05-24 Impact factor: 3.494
Authors: Paola Bermudez-Lekerika; Katherine B Crump; Sofia Tseranidou; Andrea Nüesch; Exarchos Kanelis; Ahmad Alminnawi; Laura Baumgartner; Estefano Muñoz-Moya; Roger Compte; Francesco Gualdi; Leonidas G Alexopoulos; Liesbet Geris; Karin Wuertz-Kozak; Christine L Le Maitre; Jérôme Noailly; Benjamin Gantenbein Journal: Front Cell Dev Biol Date: 2022-06-29
Authors: Chenghao Zhang; Sarah E Gullbrand; Thomas P Schaer; Yian Khai Lau; Zhirui Jiang; George R Dodge; Dawn M Elliott; Robert L Mauck; Neil R Malhotra; Lachlan J Smith Journal: J Orthop Res Date: 2020-03-03 Impact factor: 3.494
Authors: Chenghao Zhang; Sarah E Gullbrand; Thomas P Schaer; Sophie Boorman; Dawn M Elliott; Weiliam Chen; George R Dodge; Robert L Mauck; Neil R Malhotra; Lachlan J Smith Journal: Tissue Eng Part A Date: 2020-08-07 Impact factor: 3.845